Legal Disclaimer: This article provides general legal information only. Laws vary by jurisdiction, and individual circumstances differ substantially. Consult a licensed attorney in your state for advice specific to your situation.
The Growing Problem
Drug-impaired driving has become as significant as drunk driving in crash statistics. According to the Governors Highway Safety Association (GHSA), 44% of fatally injured drivers tested positive for drugs in recent studies. This figure exceeds the percentage testing positive for alcohol.
The drugs involved span multiple categories: marijuana, opioids, benzodiazepines, amphetamines, and others. Unlike alcohol, where a 0.08% BAC creates per se impairment, most drugs have no equivalent bright-line standard. This absence complicates both enforcement and civil litigation.
Types of Drug Impairment
Illicit Drugs
Marijuana, cocaine, heroin, methamphetamine, and other controlled substances cause impairment. Marijuana impairs judgment, slows reaction time, and affects lane maintenance. Stimulants may initially enhance alertness but lead to risk-taking and eventual crash when effects wear off.
Prescription Medications
Legal medications can impair driving. Opioid painkillers, benzodiazepines (anxiety medications), sleep aids, and certain antidepressants carry driving warnings. A driver taking prescribed medication as directed may still be impaired and may still be negligent.
Over-the-Counter Medications
Antihistamines, sleep aids, and cold medicines can cause drowsiness. Drivers often underestimate OTC medication effects, but impairment is impairment regardless of the medication’s legal status.
Polydrug Combinations
Many impaired drivers test positive for multiple substances. Combinations of alcohol and drugs, or multiple drugs together, create compounded impairment. Effects may be additive or synergistic, making prediction difficult.
Proof Challenges
No Per Se Standard
Unlike alcohol’s 0.08% BAC threshold, most states have no established per se limits for drugs. A positive test for THC does not automatically prove impairment because THC metabolites remain detectable long after impairment ends.
Some states have enacted zero-tolerance laws making any detectable drug presence illegal. Others require proof that the detected drug actually impaired driving ability.
Metabolite Persistence
Many drugs persist in the body far longer than their impairing effects. Marijuana metabolites remain detectable for days or weeks after last use. A positive test proves prior use but not impairment at the time of the crash.
This persistence creates evidentiary challenges. The plaintiff must connect the presence of the substance to actual impairment at the relevant time, not merely to prior consumption.
Drug Recognition Experts
The primary tool for proving drug impairment is the Drug Recognition Expert (DRE) evaluation. DREs are specially trained law enforcement officers who conduct systematic evaluations to identify drug impairment.
The DRE Protocol
The DRE protocol includes 12 steps: breath alcohol test, interview of arresting officer, preliminary examination, eye examinations (including pupil size under different lighting), divided attention tests, vital signs, dark room examination, muscle tone examination, injection site examination, suspect statements, DRE opinion, and toxicological examination.
Based on these observations, the DRE forms an opinion about whether the suspect is impaired and, if so, by what category of drugs.
Admissibility of DRE Evidence
DRE testimony is generally admissible in civil cases, though defense attorneys challenge the methodology’s reliability. Courts have mostly accepted DRE evidence, recognizing that it represents the best available tool for drug impairment detection.
The DRE does not need to identify the specific drug, only the category. Categories include central nervous system depressants, inhalants, dissociative anesthetics, cannabis, central nervous system stimulants, hallucinogens, and narcotic analgesics.
Toxicological Testing
Blood Tests
Blood tests detect drugs and metabolites. Testing typically uses immunoassay screening followed by confirmatory testing (gas chromatography-mass spectrometry). Results show what substances were present in the blood.
Timing matters. Blood should be drawn as soon as possible after the crash to capture impairment-relevant levels. Delays reduce detectability and weaken the correlation to impairment.
Urine Tests
Urine tests detect drug metabolites but are less useful for proving impairment at a specific time. Metabolites in urine indicate prior use without establishing when use occurred or whether the user was impaired.
5-Panel and 10-Panel Screens
Standard toxicology screens test for common drug categories. A 5-panel screen typically covers marijuana, cocaine, opiates, amphetamines, and PCP. A 10-panel screen adds benzodiazepines, barbiturates, methadone, propoxyphene, and methaqualone.
Expanded panels can test for specific drugs of concern based on case circumstances.
Circumstantial Evidence
Beyond testing and DRE evaluation, circumstantial evidence helps prove drug impairment.
Observable Impairment
Witnesses may describe erratic driving, slurred speech, dilated or constricted pupils, lack of coordination, or other signs of impairment. Officers document their observations in reports.
Drug Paraphernalia
Finding drug paraphernalia in the vehicle (pipes, needles, pill bottles without prescriptions) supports inference of recent use.
Defendant Statements
Defendants sometimes admit to drug use. Statements to officers, EMTs, or hospital staff may reveal what substances the defendant consumed.
Prescription Records
Subpoenaing pharmacy records can reveal what medications the defendant was prescribed. If the defendant was taking multiple sedating medications simultaneously, impairment becomes more likely.
Proving Causation
Establishing impairment is not enough; the plaintiff must prove impairment caused the crash. A driver who tested positive for marijuana but crashed due to a mechanical failure was not harmed by the drug use.
Accident reconstruction connects impairment to crash causation. Did the defendant fail to brake appropriately? Did they drift from their lane? Did their reaction time appear slowed? These behaviors consistent with impairment support causation.
Prescription Drug Issues
Prescription drug cases present additional complexities. The defendant may argue they followed doctor’s orders and had no reason to believe driving was unsafe.
However, medication warnings and instructions address driving. A defendant who drove contrary to label warnings or doctor advice was negligent. A defendant who drove consistent with warnings may argue they exercised reasonable care.
Pharmacist records, physician notes, and medication guides become relevant evidence. Did the defendant receive warnings? Did they follow them?
Employer Liability
When employees cause drug-impaired crashes during work, employer liability follows. Employers face additional exposure if they failed to implement required drug testing.
Commercial motor vehicle operators must participate in DOT drug testing programs. Failing to test, or allowing employees to drive after positive tests, creates direct employer negligence.
Insurance Considerations
Drug-impaired driving crashes are typically covered by liability insurance. Like DUI, the conduct is negligent rather than intentional.
Punitive damages for egregious drug impairment may be uninsurable, exposing defendants personally.
Key Takeaways:
Drug-impaired drivers constitute 44% of fatally injured drivers according to GHSA data. Unlike alcohol, most drugs have no per se impairment standard, complicating proof. Drug Recognition Experts (DREs) conduct systematic evaluations to identify impairment categories. Toxicological testing detects substances but does not automatically prove impairment at crash time. Circumstantial evidence (observable impairment, paraphernalia, statements) supplements testing and DRE evaluation. Prescription medication cases require analysis of warnings and whether the defendant followed them.
Sources:
- Drug-positive driver statistics: Governors Highway Safety Association (GHSA) drug-impaired driving reports
- DRE protocol: International Association of Chiefs of Police DRE program
- DOT drug testing requirements: 49 CFR Part 40